Westchester Capital Management (New York)’s Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 SOAR.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding SOAR.WS
Westchester Capital Management (New York)'s SOAR.WS Position: Q4 2024 in Review
Westchester Capital Management (New York) sold out of Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (SOAR.WS) in Q4 2024, closing a stake of 200,000 shares — an estimated $1.02K sold.
Westchester Capital Management (New York) first reported a position in SOAR.WS in Q1 2023 and held it in 7 quarters. The position peaked at $30K in Q1 2024. 1 fund tracked by Wall St. Rank holds SOAR.WS as of Q4 2024.
- Westchester Capital Management (New York) reported no remaining Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q4 2024 after selling out during the quarter.
- Westchester Capital Management (New York) sold 200,000 Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q4 2024, an estimated $1.02K.
- Westchester Capital Management (New York) first reported a position in Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2023 and held it in 7 quarters.
- Westchester Capital Management (New York)'s Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $30K in Q1 2024.
- 1 fund tracked by Wall St. Rank held Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q4 2024.
Based on Westchester Capital Management (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.